Supporting evidence

• LedgerMixed quarter based on: Focus on securities cessation, not operational results · No financial metrics provided · Neutral management tone · No guidance updates.
• GuidanceGuidance: Elevra has maintained its FY26 guidance, expecting robust spodumene concentrate production and sales, alongside a continued focus on cost management. The compan…
• EventSecurities Adjustment

• EventNo Operational Updates
• EventRepresents new equity-based incentives or compensation.
• EventIndicates some equity-based incentives did not vest.
• EventEnhances future value realization from Moblan, increases flexibility for supply agreements and financing opportunities, and was structured as an equity-based deal to conserve cash.
• InitiativeGroundbreaking has occurred, funding secured, and equipment orders are being placed. Stage 1 expected completion by mid-CY27. Stage 3 construction forecast to be completed by mid-C…
• InitiativeEvidenced by the decision to transition from OTCQB Venture Market to save costs.
• InitiativeScoping study completed, indicating a strong economic case.
• InitiativeInitial 15-20% increase expected mid-CY27, subsequent expansion to 6,500 tpd by early CY28, final step by early CY29.
• EventLack of operational transparency